Data completeness
1/8 — Limited
TEGOPEN (cloxacillin sodium) by Bristol Myers Squibb is action: cloxacillin benzathine is bactericidal in action against susceptible organisms during the stage of active multiplication.
Drug data last refreshed 2w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TEGOPEN (cloxacillin sodium) is an oral penicillinase-resistant penicillin antibiotic formulated as a solution for reconstitution. It is bactericidal, inhibiting bacterial cell wall synthesis and is active against gram-positive organisms including penicillin G-resistant Staphylococcus aureus. The drug is indicated for treating infections caused by susceptible organisms, particularly in veterinary/mastitis contexts based on available labeling.
Pre-Launch
Product is in pre-launch phase with no current commercial data; teams should expect infrastructure build-out and market entry planning activities.
Mechanism of Action
ACTION: Cloxacillin benzathine is bactericidal in action against susceptible organisms during the stage of active multiplication. It acts through the inhibition of biosynthesis of cell wall mucopeptide. It is active against gram-positive organisms associated with mastitis such as Staphylococcus…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
TEGOPEN is in pre-launch phase sponsored by Bristol Myers Squibb with zero linked job postings, indicating early-stage portfolio work. Professionals joining this product now would be involved in foundational commercial strategy, regulatory clearance, and market entry planning rather than mature brand management.
Brand Manager
Worked on TEGOPEN at Bristol Myers Squibb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.